MTOR Kinase Leads to PTEN-loss-induced Cellular Senescence by Phosphorylating P53

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2018 Oct 20

PMID 30337688

Citations 72

Authors

Seung Hee Jung

Hyun Jung Hwang

Donghee Kang

Hyun A Park

Hyung Chul Lee

Daecheol Jeong

Keunwook Lee

Heon Joo Park

Young-Gyu Ko

Jae-Seon Lee

Affiliations

Soon will be listed here.

Abstract

Loss of PTEN, the major negative regulator of the PI3K/AKT pathway induces a cellular senescence as a failsafe mechanism to defend against tumorigenesis, which is called PTEN-loss-induced cellular senescence (PICS). Although many studies have indicated that the mTOR pathway plays a critical role in cellular senescence, the exact functions of mTORC1 and mTORC2 in PICS are not well understood. In this study, we show that mTOR acts as a critical relay molecule downstream of PI3K/AKT and upstream of p53 in PICS. We found that PTEN depletion induces cellular senescence via p53-p21 signaling without triggering DNA damage response. mTOR kinase, a major component of mTORC1 and mTORC2, directly binds p53 and phosphorylates it at serine 15. mTORC1 and mTORC2 compete with MDM2 and increase the stability of p53 to induce cellular senescence via accumulation of the cell cycle inhibitor, p21. In embryonic fibroblasts of PTEN-knockout mice, PTEN deficiency also induces mTORC1 and mTORC2 to bind to p53 instead of MDM2, leading to cellular senescence. These results collectively demonstrate for the first time that mTOR plays a critical role in switching cells from proliferation signaling to senescence signaling via a direct link between the growth-promoting activity of AKT and the growth-suppressing activity of p53.

Citing Articles

Chromosome mis-segregation triggers cell cycle arrest through a mechanosensitive nuclear envelope checkpoint.

Herve S, Scelfo A, Bersano Marchisio G, Grison M, Vaidziulyte K, Dumont M Nat Cell Biol. 2025; 27(1):73-86.

PMID: 39779939 PMC: 11735390. DOI: 10.1038/s41556-024-01565-x.

All-trans retinoic acid inhibits glioblastoma progression and attenuates radiation-induced brain injury.

Fu M, Zhang Y, Peng B, Luo N, Zhang Y, Zhu W JCI Insight. 2024; 9(21).

PMID: 39513361 PMC: 11601587. DOI: 10.1172/jci.insight.179530.

Loss of myosin light chain kinase induces the cellular senescence associated secretory phenotype to promote breast epithelial cell migration.

Kim D, Cooper J, Helfman D Sci Rep. 2024; 14(1):25786.

PMID: 39468273 PMC: 11519378. DOI: 10.1038/s41598-024-76868-y.

Senescence in the ageing skin: a new focus on mTORC1 and the lysosome.

Smith P, Carroll B FEBS J. 2024; 292(5):960-975.

PMID: 39325694 PMC: 11880983. DOI: 10.1111/febs.17281.

The potential of flavonoids to mitigate cellular senescence in cardiovascular disease.

Zheng H, Li T, Hu Z, Zheng Q, Wang J Biogerontology. 2024; 25(6):985-1010.

PMID: 39325277 DOI: 10.1007/s10522-024-10141-7.

References

Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S . Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002; 110(2):177-89. DOI: 10.1016/s0092-8674(02)00833-4. View

dAdda di Fagagna F, Reaper P, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T . A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003; 426(6963):194-8. DOI: 10.1038/nature02118. View

Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I . Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004; 23(1):212-20. PMC: 1271675. DOI: 10.1038/sj.emboj.7600045. View

Sarbassov D, Ali S, Kim D, Guertin D, Latek R, Erdjument-Bromage H . Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004; 14(14):1296-302. DOI: 10.1016/j.cub.2004.06.054. View

Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg M, Hall A . Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol. 2004; 6(11):1122-8. DOI: 10.1038/ncb1183. View

Lowe S, Cepero E, Evan G . Intrinsic tumour suppression. Nature. 2004; 432(7015):307-15. DOI: 10.1038/nature03098. View

Sarbassov D, Guertin D, Ali S, Sabatini D . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307(5712):1098-101. DOI: 10.1126/science.1106148. View

Chen Z, Trotman L, Shaffer D, Lin H, Dotan Z, Niki M . Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005; 436(7051):725-30. PMC: 1939938. DOI: 10.1038/nature03918. View

Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N . Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006; 444(7119):633-7. DOI: 10.1038/nature05268. View

10.

Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C . Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006; 444(7119):638-42. DOI: 10.1038/nature05327. View

11.

Sancak Y, Thoreen C, Peterson T, Lindquist R, Kang S, Spooner E . PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell. 2007; 25(6):903-15. DOI: 10.1016/j.molcel.2007.03.003. View

12.

Bhaskar P, Hay N . The two TORCs and Akt. Dev Cell. 2007; 12(4):487-502. DOI: 10.1016/j.devcel.2007.03.020. View

13.

Courtois-Cox S, Jones S, Cichowski K . Many roads lead to oncogene-induced senescence. Oncogene. 2008; 27(20):2801-9. DOI: 10.1038/sj.onc.1210950. View

14.

Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C . The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 2008; 27(14):1932-43. PMC: 2486276. DOI: 10.1038/emboj.2008.120. View

15.

Garcia-Martinez J, Alessi D . mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J. 2008; 416(3):375-85. DOI: 10.1042/BJ20081668. View

16.

Nogueira V, Park Y, Chen C, Xu P, Chen M, Tonic I . Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008; 14(6):458-70. PMC: 3038665. DOI: 10.1016/j.ccr.2008.11.003. View

17.

Moral M, Segrelles C, Lara M, Martinez-Cruz A, Lorz C, Santos M . Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma. Cancer Res. 2009; 69(3):1099-108. PMC: 2914485. DOI: 10.1158/0008-5472.CAN-08-3240. View

18.

Puzio-Kuter A, Castillo-Martin M, Kinkade C, Wang X, Shen T, Matos T . Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev. 2009; 23(6):675-80. PMC: 2661614. DOI: 10.1101/gad.1772909. View

19.

Kruse J, Gu W . Modes of p53 regulation. Cell. 2009; 137(4):609-22. PMC: 3737742. DOI: 10.1016/j.cell.2009.04.050. View

20.

Fujita K, Mondal A, Horikawa I, Nguyen G, Kumamoto K, Sohn J . p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol. 2009; 11(9):1135-42. PMC: 2802853. DOI: 10.1038/ncb1928. View